-
1
-
-
0035930175
-
From the World Health Organization. Mental health: New understanding, new hope
-
Brundtland GH. From the World Health Organization. Mental health: new understanding, new hope. JAMA 2001; 286:2391.
-
(2001)
JAMA
, vol.286
, pp. 2391
-
-
Brundtland, G.H.1
-
2
-
-
70349217937
-
Cardiovascular disease and diabetes in people with severe mental illness: Position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
-
De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Moller HJ. Cardiovascular disease and diabetes in people with severe mental illness: position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 2009;24: 412-24.
-
(2009)
Eur Psychiatry
, vol.24
, pp. 412-424
-
-
De Hert, M.1
Dekker, J.M.2
Wood, D.3
Kahl, K.G.4
Holt, R.I.5
Moller, H.J.6
-
3
-
-
34948840329
-
A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time?
-
Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007;64:1123-31.
-
(2007)
Arch Gen Psychiatry
, vol.64
, pp. 1123-1131
-
-
Saha, S.1
Chant, D.2
McGrath, J.3
-
4
-
-
0036280163
-
Mortality of patients with mood disorders: Follow-up over 34-38 years
-
Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002;68:167-81.
-
(2002)
J Affect Disord
, vol.68
, pp. 167-181
-
-
Angst, F.1
Stassen, H.H.2
Clayton, P.J.3
Angst, J.4
-
5
-
-
0030799116
-
Price of adaptation - Allostatic load and its health consequences. MacArthur studies of successful aging
-
Seeman TE, Singer BH, Rowe JW, Horwitz RI, McEwen BS. Price of adaptation - allostatic load and its health consequences. MacArthur studies of successful aging. Arch Intern Med 1997;157:2259-68.
-
(1997)
Arch Intern Med
, vol.157
, pp. 2259-2268
-
-
Seeman, T.E.1
Singer, B.H.2
Rowe, J.W.3
Horwitz, R.I.4
McEwen, B.S.5
-
6
-
-
84866640082
-
A systematic review of allostatic load, health, and health disparities
-
Beckie TM. A systematic review of allostatic load, health, and health disparities. Biol Res Nurs 2012;14:311-46.
-
(2012)
Biol Res Nurs
, vol.14
, pp. 311-346
-
-
Beckie, T.M.1
-
7
-
-
77955919761
-
Allostatic load biomarkers of chronic stress and impacton health and cognition
-
Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impacton health and cognition. Neurosci Biobehav Rev 2010;35:2-16.
-
(2010)
Neurosci Biobehav Rev
, vol.35
, pp. 2-16
-
-
Juster, R.P.1
McEwen, B.S.2
Lupien, S.J.3
-
8
-
-
40149096962
-
Allostatic load in bipolar disorder: Implications for pathophysiology and treatment
-
Kapczinski F, Vieta E, Andreazza AC, et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 2008;32:675-92.
-
(2008)
Neurosci Biobehav Rev
, vol.32
, pp. 675-692
-
-
Kapczinski, F.1
Vieta, E.2
Andreazza, A.C.3
-
9
-
-
0000310973
-
Allostasis: A new paradigm to explain arousal pathology
-
Fisher S, Reason J, eds. New York: Wiley
-
Sterling P, Eyer J. Allostasis: a new paradigm to explain arousal pathology. In: Fisher S, Reason J, eds. Handbook of life stress, cognition and health. New York: Wiley, 1988:629-49.
-
(1988)
Handbook of Life Stress, Cognition and Health
, pp. 629-649
-
-
Sterling, P.1
Eyer, J.2
-
10
-
-
84954243686
-
Principles of allostasis: Optimal design, predictive regulation, pathophysiology and rational therapeutics
-
Schulkin J, ed. Cambridge: Cambridge University Press
-
Sterling P. Principles of allostasis: optimal design, predictive regulation, pathophysiology and rational therapeutics. In: Schulkin J, ed. Allostasis, homeostasis, and the costs of adaptation. Cambridge: Cambridge University Press, 2004:17-64.
-
(2004)
Allostasis, Homeostasis, and the Costs of Adaptation
, pp. 17-64
-
-
Sterling, P.1
-
11
-
-
0037220421
-
Allostasis: A neural behavioral perspective
-
discussion 8-30
-
Schulkin J. Allostasis: a neural behavioral perspective. Horm Behav 2003;43:21-7; discussion 8-30.
-
(2003)
Horm Behav
, vol.43
, pp. 21-27
-
-
Schulkin, J.1
-
12
-
-
0034454682
-
How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions
-
Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000;21:55-89.
-
(2000)
Endocr Rev
, vol.21
, pp. 55-89
-
-
Sapolsky, R.M.1
Romero, L.M.2
Munck, A.U.3
-
13
-
-
0032078238
-
Stress, adaptation, and disease. Allostasis and allostatic load
-
McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci 1998;840:33-44.
-
(1998)
Ann N y Acad Sci
, vol.840
, pp. 33-44
-
-
McEwen, B.S.1
-
14
-
-
0027515623
-
Stress and the individual. Mechanisms leading to disease
-
McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med 1993;153:2093-101.
-
(1993)
Arch Intern Med
, vol.153
, pp. 2093-2101
-
-
McEwen, B.S.1
Stellar, E.2
-
15
-
-
0034142298
-
Allostasis and allostatic load: Implications for neuropsychopharmacology
-
McEwen BS. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 2000;22:108-24.
-
(2000)
Neuropsychopharmacology
, vol.22
, pp. 108-124
-
-
McEwen, B.S.1
-
16
-
-
84870495336
-
Chronic stress and allostatic load
-
Schenck-Gustafsson K, DeCola PR, Pfaff DW, Pisetsky DS, eds. Basel: Karger
-
Juster RP, Lupien SJ. Chronic stress and allostatic load. In: Schenck-Gustafsson K, DeCola PR, Pfaff DW, Pisetsky DS, eds. Handbook of clinical gender medicine. Basel: Karger, 2012:70-81.
-
(2012)
Handbook of Clinical Gender Medicine
, pp. 70-81
-
-
Juster, R.P.1
Lupien, S.J.2
-
17
-
-
0030799116
-
Price of adaptation - Allostatic load and its health consequences
-
Seeman E, Singer BH, Rowe J, Horwitz RI, McEwen B. Price of adaptation - allostatic load and its health consequences. Arch Intern Med 1997;157:2259-68.
-
(1997)
Arch Intern Med
, vol.157
, pp. 2259-2268
-
-
Seeman, E.1
Singer, B.H.2
Rowe, J.3
Horwitz, R.I.4
McEwen, B.5
-
18
-
-
42049117789
-
Diverse pathways to positive and negative affect in adulthood and later life: An integrative approach using recursive partitioning
-
Gruenewald TL, Mroczek DK, Ryff CD, Singer BH. Diverse pathways to positive and negative affect in adulthood and later life: an integrative approach using recursive partitioning. Dev Psychol 2008;44:330-43.
-
(2008)
Dev Psychol
, vol.44
, pp. 330-343
-
-
Gruenewald, T.L.1
Mroczek, D.K.2
Ryff, C.D.3
Singer, B.H.4
-
19
-
-
0035836692
-
Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging
-
Seeman TE, McEwen BS, Rowe JW, Singer BH. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci U S A 2001;98: 4770-5.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 4770-4775
-
-
Seeman, T.E.1
McEwen, B.S.2
Rowe, J.W.3
Singer, B.H.4
-
20
-
-
33750075775
-
Physiological dysregulation and changes in health in an older population
-
Goldman N, Turra CM, Glei DA, Lin YH, Weinstein M. Physiological dysregulation and changes in health in an older population. Exp Gerontol 2006;41:862-70.
-
(2006)
Exp Gerontol
, vol.41
, pp. 862-870
-
-
Goldman, N.1
Turra, C.M.2
Glei, D.A.3
Lin, Y.H.4
Weinstein, M.5
-
21
-
-
33750906417
-
Predicting mortality from clinical and nonclinical biomarkers
-
Goldman N, Turra CM, Glei DA, Seplaki CL, Lin YH, Weinstein M. Predicting mortality from clinical and nonclinical biomarkers. J Gerontol A Biol Sci Med Sci 2006;61:1070-4.
-
(2006)
J Gerontol a Biol Sci Med Sci
, vol.61
, pp. 1070-1074
-
-
Goldman, N.1
Turra, C.M.2
Glei, D.A.3
Seplaki, C.L.4
Lin, Y.H.5
Weinstein, M.6
-
22
-
-
20144377464
-
A comparative analysis of measurement approaches for physiological dysregulation in an older population
-
Seplaki CL, Goldman N, Glei D, Weinstein M. A comparative analysis of measurement approaches for physiological dysregulation in an older population. Exp Gerontol 2005;40:438-49.
-
(2005)
Exp Gerontol
, vol.40
, pp. 438-449
-
-
Seplaki, C.L.1
Goldman, N.2
Glei, D.3
Weinstein, M.4
-
23
-
-
1642275619
-
How are biomarkers related to physical and mental well-being?
-
Seplaki CL, Goldman N, Weinstein M, Lin YH. How are biomarkers related to physical and mental well-being? J Gerentol 2004;59A:201-17.
-
(2004)
J Gerentol
, vol.59
, Issue.A
, pp. 201-217
-
-
Seplaki, C.L.1
Goldman, N.2
Weinstein, M.3
Lin, Y.H.4
-
24
-
-
33646793648
-
Measurement of cumulative physiological dysregulation in an older population
-
Seplaki CL, Goldman N, Weinstein M, Lin YH. Measurement of cumulative physiological dysregulation in an older population. Demography 2006;43:165-83.
-
(2006)
Demography
, vol.43
, pp. 165-183
-
-
Seplaki, C.L.1
Goldman, N.2
Weinstein, M.3
Lin, Y.H.4
-
25
-
-
33746099750
-
Reduction in allostatic load in older adults is associated with lower allcause mortality risk: MacArthur studies of successful aging
-
Karlamangla AS, Singer BH, Seeman TE. Reduction in allostatic load in older adults is associated with lower allcause mortality risk: MacArthur studies of successful aging. Psychosom Med 2006;68:500-7.
-
(2006)
Psychosom Med
, vol.68
, pp. 500-507
-
-
Karlamangla, A.S.1
Singer, B.H.2
Seeman, T.E.3
-
26
-
-
44849100969
-
Comorbid somatic illnesses in patients with severe mental disorders: Clinical, policy, and research challenges
-
Fleischhacker WW, Cetkovich-Bakmas M, De Hert M, et al. Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J Clin Psychiatry 2008;69:514-9.
-
(2008)
J Clin Psychiatry
, vol.69
, pp. 514-519
-
-
Fleischhacker, W.W.1
Cetkovich-Bakmas, M.2
De Hert, M.3
-
27
-
-
0030694189
-
Excess mortality of schizophrenia: A meta-analysis
-
Brown S. Excess mortality of schizophrenia: a meta-analysis. Br J Psychiatry 1997;171:502-8.
-
(1997)
Br J Psychiatry
, vol.171
, pp. 502-508
-
-
Brown, S.1
-
28
-
-
33748561486
-
Medical risk in patients with bipolar disorder and schizophrenia
-
discussion 36-42
-
Newcomer JW. Medical risk in patients with bipolar disorder and schizophrenia. J Clin Psychiatry 2006;67 suppl 9:25-30; discussion 36-42.
-
(2006)
J Clin Psychiatry
, vol.67
, Issue.SUPPL. 9
, pp. 25-30
-
-
Newcomer, J.W.1
-
29
-
-
0034686911
-
Time trends in schizophrenia mortality in Stockholm county, Sweden: Cohort study
-
Osby U, Correia N, Brandt L, Ekbom A, Sparen P. Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study. BMJ 2000;321:483-4.
-
(2000)
BMJ
, vol.321
, pp. 483-484
-
-
Osby, U.1
Correia, N.2
Brandt, L.3
Ekbom, A.4
Sparen, P.5
-
31
-
-
33744913823
-
Diabetes and schizophrenia 2005: Are we any closer to understanding the link?
-
Holt RI, Bushe C, Citrome L. Diabetes and schizophrenia 2005: are we any closer to understanding the link? J Psychopharmacol 2005;19:56-65.
-
(2005)
J Psychopharmacol
, vol.19
, pp. 56-65
-
-
Holt, R.I.1
Bushe, C.2
Citrome, L.3
-
32
-
-
22044436909
-
Bipolar disorder and diabetes mellitus: Epidemiology, etiology, and treatment implications
-
McIntyre RS, Konarski JZ, Misener VL, Kennedy SH. Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Ann Clin Psychiatry 2005;17:83-93.
-
(2005)
Ann Clin Psychiatry
, vol.17
, pp. 83-93
-
-
McIntyre, R.S.1
Konarski, J.Z.2
Misener, V.L.3
Kennedy, S.H.4
-
33
-
-
0242302508
-
Interacting mediators of allostasis and allostatic load: Towards an understanding of resilience in aging
-
McEwen BS. Interacting mediators of allostasis and allostatic load: towards an understanding of resilience in aging. Metabolism 2003;52:10-6.
-
(2003)
Metabolism
, vol.52
, pp. 10-16
-
-
McEwen, B.S.1
-
34
-
-
0032518022
-
Protective and damaging effects of stress mediators
-
McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998;338:171-9.
-
(1998)
N Engl J Med
, vol.338
, pp. 171-179
-
-
McEwen, B.S.1
-
35
-
-
3543112049
-
Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women
-
Muck-Seler D, Pivac N, Mustapic M, Crncevic Z, Jakovljevic M, Sagud M. Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women. Psychiatry Res 2004;127:217-26.
-
(2004)
Psychiatry Res
, vol.127
, pp. 217-226
-
-
Muck-Seler, D.1
Pivac, N.2
Mustapic, M.3
Crncevic, Z.4
Jakovljevic, M.5
Sagud, M.6
-
36
-
-
13844271916
-
Male patients with paranoid schizophrenia have greater ACTH and cortisol secretion in response to metoclopramide-induced AVP release
-
Walsh P, Spelman L, Sharifi N, Thakore JH. Male patients with paranoid schizophrenia have greater ACTH and cortisol secretion in response to metoclopramide-induced AVP release. Psychoneuroendocrinology 2005;30:431-7.
-
(2005)
Psychoneuroendocrinology
, vol.30
, pp. 431-437
-
-
Walsh, P.1
Spelman, L.2
Sharifi, N.3
Thakore, J.H.4
-
37
-
-
33846643951
-
Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder
-
Gallagher P, Watson S, Smith MS, Young AH, Ferrier IN. Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder. Schizophr Res 2007;90: 258-65.
-
(2007)
Schizophr Res
, vol.90
, pp. 258-265
-
-
Gallagher, P.1
Watson, S.2
Smith, M.S.3
Young, A.H.4
Ferrier, I.N.5
-
38
-
-
33846402115
-
State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients
-
Ritsner M, Gibel A, Maayan R, et al. State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients. Eur Neuropsychopharmacol 2007;17:257-64.
-
(2007)
Eur Neuropsychopharmacol
, vol.17
, pp. 257-264
-
-
Ritsner, M.1
Gibel, A.2
Maayan, R.3
-
39
-
-
33847058371
-
Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia
-
Yilmaz N, Herken H, Cicek HK, Celik A, Yurekli M, Akyol O. Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia. Med Princ Pract 2007;16:137-41.
-
(2007)
Med Princ Pract
, vol.16
, pp. 137-141
-
-
Yilmaz, N.1
Herken, H.2
Cicek, H.K.3
Celik, A.4
Yurekli, M.5
Akyol, O.6
-
40
-
-
0027959021
-
The 24-hour profiles of cortisol, prolactin, and growth hormone secretion in mania
-
Linkowski P, Kerkhofs M, Van Onderbergen A, et al. The 24-hour profiles of cortisol, prolactin, and growth hormone secretion in mania. Arch Gen Psychiatry 1994;51:616-24.
-
(1994)
Arch Gen Psychiatry
, vol.51
, pp. 616-624
-
-
Linkowski, P.1
Kerkhofs, M.2
Van Onderbergen, A.3
-
41
-
-
0345466578
-
Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients
-
Muck-Seler D, Pivac N, Jakovljevic M, Brzovic Z. Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients. Biol Psychiatry 1999;45:1433-9.
-
(1999)
Biol Psychiatry
, vol.45
, pp. 1433-1439
-
-
Muck-Seler, D.1
Pivac, N.2
Jakovljevic, M.3
Brzovic, Z.4
-
43
-
-
33750797822
-
Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior
-
Sher L. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior. ScientificWorldJournal 2006;6:1398-404.
-
(2006)
ScientificWorldJournal
, vol.6
, pp. 1398-1404
-
-
Sher, L.1
-
44
-
-
2642581632
-
Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder
-
Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 2004;184:496-502.
-
(2004)
Br J Psychiatry
, vol.184
, pp. 496-502
-
-
Watson, S.1
Gallagher, P.2
Ritchie, J.C.3
Ferrier, I.N.4
Young, A.H.5
-
45
-
-
0030889592
-
Prediction of depressive relapse in remitted bipolar patients using corticotrophin-releasing hormone challenge test
-
Vieta E, Gasto C, Martinez de Osaba MJ, et al. Prediction of depressive relapse in remitted bipolar patients using corticotrophin-releasing hormone challenge test. Acta Psychiatr Scand 1997;95:205-11.
-
(1997)
Acta Psychiatr Scand
, vol.95
, pp. 205-211
-
-
Vieta, E.1
Gasto, C.2
Martinez De Osaba, M.J.3
-
46
-
-
58049137940
-
Neurobiological and neuropsychiatric effects of dehydroepi-androsterone (DHEA) and DHEA sulfate (DHEAS)
-
Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH. Neurobiological and neuropsychiatric effects of dehydroepi-androsterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol 2009;30:65-91.
-
(2009)
Front Neuroendocrinol
, vol.30
, pp. 65-91
-
-
Maninger, N.1
Wolkowitz, O.M.2
Reus, V.I.3
Epel, E.S.4
Mellon, S.H.5
-
47
-
-
40949107708
-
Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review
-
Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 2008;63: 801-8.
-
(2008)
Biol Psychiatry
, vol.63
, pp. 801-808
-
-
Potvin, S.1
Stip, E.2
Sepehry, A.A.3
Gendron, A.4
Bah, R.5
Kouassi, E.6
-
48
-
-
12244286806
-
High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder
-
Breunis MN, Kupka RW, Nolen WA, et al. High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder. Biol Psychiatry 2003;53:157-65.
-
(2003)
Biol Psychiatry
, vol.53
, pp. 157-165
-
-
Breunis, M.N.1
Kupka, R.W.2
Nolen, W.A.3
-
49
-
-
35948958993
-
Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
-
Kim YK, Jung HG, Myint AM, Kim H, Park SH. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord 2007;104:91-5.
-
(2007)
J Affect Disord
, vol.104
, pp. 91-95
-
-
Kim, Y.K.1
Jung, H.G.2
Myint, A.M.3
Kim, H.4
Park, S.H.5
-
50
-
-
1842737767
-
Immunologic variables in acute mania of bipolar disorder
-
Liu HC, Yang YY, Chou YM, Chen KP, Shen WW, Leu SJ. Immunologic variables in acute mania of bipolar disorder. J Neuroimmunol 2004;150:116-22.
-
(2004)
J Neuroimmunol
, vol.150
, pp. 116-122
-
-
Liu, H.C.1
Yang, Y.Y.2
Chou, Y.M.3
Chen, K.P.4
Shen, W.W.5
Leu, S.J.6
-
51
-
-
31844457040
-
Cytokine profiles in bipolar affective disorder: Focus on acutely ill patients
-
O'Brien SM, Scully P, Scott LV, Dinan TG. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord 2006;90:263-7.
-
(2006)
J Affect Disord
, vol.90
, pp. 263-267
-
-
O'Brien, S.M.1
Scully, P.2
Scott, L.V.3
Dinan, T.G.4
-
53
-
-
0033560674
-
Activation of indices of cell-mediated immunity in bipolar mania
-
Tsai SY, Chen KP, Yang YY, et al. Activation of indices of cell-mediated immunity in bipolar mania. Biol Psychiatry 1999;45:989-94.
-
(1999)
Biol Psychiatry
, vol.45
, pp. 989-994
-
-
Tsai, S.Y.1
Chen, K.P.2
Yang, Y.Y.3
-
54
-
-
6944237757
-
Adipokines: Inflammation and the pleiotropic role of white adipose tissue
-
Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92: 347-55.
-
(2004)
Br J Nutr
, vol.92
, pp. 347-355
-
-
Trayhurn, P.1
Wood, I.S.2
-
55
-
-
71649115889
-
Depression, traumatic stress and interleukin-6
-
Bob P, Raboch J, Maes M, et al. Depression, traumatic stress and interleukin-6. J Affect Disord 2010;120:231-4.
-
(2010)
J Affect Disord
, vol.120
, pp. 231-234
-
-
Bob, P.1
Raboch, J.2
Maes, M.3
-
56
-
-
68749094080
-
Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States
-
Goldstein BI, Fagiolini A, Houck P, Kupfer DJ. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord 2009;11:657-62.
-
(2009)
Bipolar Disord
, vol.11
, pp. 657-662
-
-
Goldstein, B.I.1
Fagiolini, A.2
Houck, P.3
Kupfer, D.J.4
-
57
-
-
60349126636
-
A prospective observational study of obesity, body composition, and insulin resistance in 18 women with bipolar disorder and 17 matched control subjects
-
Fleet-Michaliszyn SB, Soreca I, Otto AD, et al. A prospective observational study of obesity, body composition, and insulin resistance in 18 women with bipolar disorder and 17 matched control subjects. J Clin Psychiatry 2008;69:1892-900.
-
(2008)
J Clin Psychiatry
, vol.69
, pp. 1892-1900
-
-
Fleet-Michaliszyn, S.B.1
Soreca, I.2
Otto, A.D.3
-
58
-
-
44849112011
-
Metabolic syndrome in patients with bipolar disorder
-
Fagiolini A, Frank E, Turkin S, Houck PR, Soreca I, Kupfer DJ. Metabolic syndrome in patients with bipolar disorder. J Clin Psychiatry 2008;69:678-9.
-
(2008)
J Clin Psychiatry
, vol.69
, pp. 678-679
-
-
Fagiolini, A.1
Frank, E.2
Turkin, S.3
Houck, P.R.4
Soreca, I.5
Kupfer, D.J.6
-
59
-
-
34247158550
-
Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases
-
Trushina E, McMurray CT. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 2007; 145:1233-48.
-
(2007)
Neuroscience
, vol.145
, pp. 1233-1248
-
-
Trushina, E.1
McMurray, C.T.2
-
60
-
-
80054925531
-
A transdisciplinary perspective of chronic stress in relation to psychopathology throughout life span development
-
Juster RP, Bizik G, Picard M, et al. A transdisciplinary perspective of chronic stress in relation to psychopathology throughout life span development. Dev Psychopathol 2011; 23:725-76.
-
(2011)
Dev Psychopathol
, vol.23
, pp. 725-776
-
-
Juster, R.P.1
Bizik, G.2
Picard, M.3
-
63
-
-
12744278045
-
Psychiatric and medical comorbidities of bipolar disorder
-
Krishnan KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med 2005;67:1-8.
-
(2005)
Psychosom Med
, vol.67
, pp. 1-8
-
-
Krishnan, K.R.1
-
64
-
-
0035096665
-
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder
-
McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001; 158:420-6.
-
(2001)
Am J Psychiatry
, vol.158
, pp. 420-426
-
-
McElroy, S.L.1
Altshuler, L.L.2
Suppes, T.3
-
65
-
-
0025226205
-
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study
-
Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264:2511-8.
-
(1990)
JAMA
, vol.264
, pp. 2511-2518
-
-
Regier, D.A.1
Farmer, M.E.2
Rae, D.S.3
-
66
-
-
84857122622
-
Allostasis and addiction: Role of the dopamine and corticotropin- releasing factor systems
-
George O, Le Moal M, Koob GF. Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems. Physiol Behav 2012;106:58-64.
-
(2012)
Physiol Behav
, vol.106
, pp. 58-64
-
-
George, O.1
Le Moal, M.2
Koob, G.F.3
-
67
-
-
0037329682
-
Alcoholism: Allostasis and beyond
-
Koob GF. Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 2003;27:232-43.
-
(2003)
Alcohol Clin Exp Res
, vol.27
, pp. 232-243
-
-
Koob, G.F.1
-
68
-
-
1042266422
-
Neurobiological mechanisms in the transition from drug use to drug dependence
-
Koob GF, Ahmed SH, Boutrel B, et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 2004;27:739-49.
-
(2004)
Neurosci Biobehav Rev
, vol.27
, pp. 739-749
-
-
Koob, G.F.1
Ahmed, S.H.2
Boutrel, B.3
-
69
-
-
0035199891
-
Drug addiction, dysregulation of reward, and allostasis
-
Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001;24: 97-129.
-
(2001)
Neuropsychopharmacology
, vol.24
, pp. 97-129
-
-
Koob, G.F.1
Le Moal, M.2
-
71
-
-
10044267876
-
Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: Implications for the development of alcoholism
-
Valdez GR, Koob GF. Allostasis and dysregulation of corticotropin- releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol Biochem Behav 2004;79:671-89.
-
(2004)
Pharmacol Biochem Behav
, vol.79
, pp. 671-689
-
-
Valdez, G.R.1
Koob, G.F.2
-
72
-
-
84857112386
-
Mediators of allostasis and systemic toxicity in bipolar disorder
-
Grande I, Magalhaes PV, Kunz M, Vieta E, Kapczinski F. Mediators of allostasis and systemic toxicity in bipolar disorder. Physiol Behav 2012;106:46-50.
-
(2012)
Physiol Behav
, vol.106
, pp. 46-50
-
-
Grande, I.1
Magalhaes, P.V.2
Kunz, M.3
Vieta, E.4
Kapczinski, F.5
-
73
-
-
0141832631
-
Mood disorders and allostatic load
-
McEwen BS. Mood disorders and allostatic load. Biol Psychiatry 2003;54:200-7.
-
(2003)
Biol Psychiatry
, vol.54
, pp. 200-207
-
-
McEwen, B.S.1
-
74
-
-
17444413709
-
Glucocorticoids, depression, and mood disorders: Structural remodeling in the brain
-
McEwen BS. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 2005;54:20-3.
-
(2005)
Metabolism
, vol.54
, pp. 20-23
-
-
McEwen, B.S.1
-
75
-
-
14544269337
-
Protection and damage from acute and chronic stress: Allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders
-
McEwen BS. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann N Y Acad Sci 2004;1032:1-7.
-
(2004)
Ann N y Acad Sci
, vol.1032
, pp. 1-7
-
-
McEwen, B.S.1
-
76
-
-
0031859325
-
Induction of corticotropin-releasing hormone gene expression by glucocorticoids: Implication for understanding the states of fear and anxiety and allostatic load
-
Schulkin J, Gold PW, McEwen BS. Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology 1998;23: 219-43.
-
(1998)
Psychoneuroendocrinology
, vol.23
, pp. 219-243
-
-
Schulkin, J.1
Gold, P.W.2
McEwen, B.S.3
-
77
-
-
0028145898
-
Allostasis, amygdala, and anticipatory angst
-
Schulkin J, McEwen BS, Gold PW. Allostasis, amygdala, and anticipatory angst. Neurosci Biobehav Rev 1994;18:385-96.
-
(1994)
Neurosci Biobehav Rev
, vol.18
, pp. 385-396
-
-
Schulkin, J.1
McEwen, B.S.2
Gold, P.W.3
-
78
-
-
0036315254
-
The neurobiology and neuroendocrinology of stress. Implications for post-traumatic stress disorder from a basic science perspective
-
ix
-
McEwen BS. The neurobiology and neuroendocrinology of stress. Implications for post-traumatic stress disorder from a basic science perspective. Psychiatr Clin North Am 2002;25: 469-94, ix.
-
(2002)
Psychiatr Clin North Am
, vol.25
, pp. 469-494
-
-
McEwen, B.S.1
-
79
-
-
0036247260
-
Is bipolar disorder specifically associated with panic disorder in youths?
-
Birmaher B, Kennah A, Brent D, Ehmann M, Bridge J, Axelson D. Is bipolar disorder specifically associated with panic disorder in youths? J Clin Psychiatry 2002;63:414-9.
-
(2002)
J Clin Psychiatry
, vol.63
, pp. 414-419
-
-
Birmaher, B.1
Kennah, A.2
Brent, D.3
Ehmann, M.4
Bridge, J.5
Axelson, D.6
-
80
-
-
0242363786
-
Subsyndromal symptoms assessed in longitudinal, prospective follow-up of a cohort of patients with bipolar disorder
-
MacQueen GM, Marriott M, Begin H, Robb J, Joffe RT, Young LT. Subsyndromal symptoms assessed in longitudinal, prospective follow-up of a cohort of patients with bipolar disorder. Bipolar Disord 2003;5:349-55.
-
(2003)
Bipolar Disord
, vol.5
, pp. 349-355
-
-
MacQueen, G.M.1
Marriott, M.2
Begin, H.3
Robb, J.4
Joffe, R.T.5
Young, L.T.6
-
81
-
-
33748786233
-
Food intake and reward mechanisms in patients with schizophrenia: Implications for metabolic disturbances and treatment with second-generation antipsychotic agents
-
Elman I, Borsook D, Lukas SE. Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents. Neuropsychopharmacology 2006;31: 2091-120.
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. 2091-2120
-
-
Elman, I.1
Borsook, D.2
Lukas, S.E.3
-
82
-
-
0141816736
-
Chronic stress and obesity: A new view of "comfort food"
-
Dallman MF, Pecoraro N, Akana SF, et al. Chronic stress and obesity: a new view of "comfort food." Proc Natl Acad Sci U S A 2003;100:11696-701.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 11696-701
-
-
Dallman, M.F.1
Pecoraro, N.2
Akana, S.F.3
-
83
-
-
84872388142
-
The clinical implications of cognitive impairment and allostatic load in bipolar disorder
-
Vieta E, Popovic D, Rosa AR, et al. The clinical implications of cognitive impairment and allostatic load in bipolar disorder. Eur Psychiatry 2013; 28:21-9.
-
(2013)
Eur Psychiatry
, vol.28
, pp. 21-29
-
-
Vieta, E.1
Popovic, D.2
Rosa, A.R.3
-
84
-
-
47249150479
-
Abnormal reward system activation in mania
-
Abler B, Greenhouse I, Ongur D, Walter H, Heckers S. Abnormal reward system activation in mania. Neuropsychopharmacology 2008;33:2217-27.
-
(2008)
Neuropsychopharmacology
, vol.33
, pp. 2217-2227
-
-
Abler, B.1
Greenhouse, I.2
Ongur, D.3
Walter, H.4
Heckers, S.5
-
85
-
-
69249145260
-
Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: Insights from PET and SPECT imaging
-
Howes OD, Egerton A, Allan V, McGuire P, Stokes P, Kapur S. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Curr Pharm Des 2009;15:2550-9.
-
(2009)
Curr Pharm Des
, vol.15
, pp. 2550-2559
-
-
Howes, O.D.1
Egerton, A.2
Allan, V.3
McGuire, P.4
Stokes, P.5
Kapur, S.6
-
86
-
-
0037223711
-
Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia
-
Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 2003;160:13-23.
-
(2003)
Am J Psychiatry
, vol.160
, pp. 13-23
-
-
Kapur, S.1
-
87
-
-
33244462829
-
How antipsychotics work - From receptors to reality
-
Kapur S, Agid O, Mizrahi R, Li M. How antipsychotics work - from receptors to reality. NeuroRx 2006;3:10-21.
-
(2006)
NeuroRx
, vol.3
, pp. 10-21
-
-
Kapur, S.1
Agid, O.2
Mizrahi, R.3
Li, M.4
-
88
-
-
0642309952
-
Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography
-
Paradiso S, Andreasen NC, Crespo-Facorro B, et al. Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography. Am J Psychiatry 2003; 160:1775-83.
-
(2003)
Am J Psychiatry
, vol.160
, pp. 1775-1783
-
-
Paradiso, S.1
Andreasen, N.C.2
Crespo-Facorro, B.3
-
89
-
-
0036897193
-
An fMRI study of facial emotion processing in patients with schizophrenia
-
Gur RE, McGrath C, Chan RM, et al. An fMRI study of facial emotion processing in patients with schizophrenia. Am J Psychiatry 2002;159:1992-9.
-
(2002)
Am J Psychiatry
, vol.159
, pp. 1992-1999
-
-
Gur, R.E.1
McGrath, C.2
Chan, R.M.3
-
90
-
-
0036512243
-
The effects of obesity, smoking, and drinking on medical problems and costs
-
Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff (Millwood) 2002; 21:245-53.
-
(2002)
Health Aff (Millwood)
, vol.21
, pp. 245-253
-
-
Sturm, R.1
-
91
-
-
84878881481
-
Obesity and psychiatric disorders: Commonalities in dysregulated biological pathways and their implications for treatment
-
Lopresti AL, Drummond PD. Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment. Prog Neuropsychopharmacol Biol Psychiatry 2013;45:92-9.
-
(2013)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.45
, pp. 92-99
-
-
Lopresti, A.L.1
Drummond, P.D.2
-
93
-
-
0141730334
-
Nutritional assessment of patients with schizophrenia: A preliminary study
-
Strassnig M, Brar JS, Ganguli R. Nutritional assessment of patients with schizophrenia: a preliminary study. Schizophr Bull 2003;29:393-7.
-
(2003)
Schizophr Bull
, vol.29
, pp. 393-397
-
-
Strassnig, M.1
Brar, J.S.2
Ganguli, R.3
-
94
-
-
0348014397
-
Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study
-
McCreadie RG. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 2003;183:534-9.
-
(2003)
Br J Psychiatry
, vol.183
, pp. 534-539
-
-
McCreadie, R.G.1
-
95
-
-
1842784860
-
Diet, diabetes and schizophrenia: Review and hypothesis
-
Peet M. Diet, diabetes and schizophrenia: review and hypothesis. Br J Psychiatry Suppl 2004;47:S102-5.
-
(2004)
Br J Psychiatry Suppl
, vol.47
-
-
Peet, M.1
-
96
-
-
67650815430
-
Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans
-
Anderson EJ, Lustig ME, Boyle KE, et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 2009;119:573-81.
-
(2009)
J Clin Invest
, vol.119
, pp. 573-581
-
-
Anderson, E.J.1
Lustig, M.E.2
Boyle, K.E.3
-
97
-
-
23844558266
-
A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine
-
Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005;39:359-407.
-
(2005)
Annu Rev Genet
, vol.39
, pp. 359-407
-
-
Wallace, D.C.1
-
98
-
-
0035878562
-
A neurobiological basis for substance abuse comorbidity in schizophrenia
-
Chambers RA, Krystal JH, Self DW. A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 2001;50:71-83.
-
(2001)
Biol Psychiatry
, vol.50
, pp. 71-83
-
-
Chambers, R.A.1
Krystal, J.H.2
Self, D.W.3
-
99
-
-
33947495416
-
The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia
-
Krystal JH, D'Souza DC, Gallinat J, et al. The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia. Neurotox Res 2006;10:235-52.
-
(2006)
Neurotox Res
, vol.10
, pp. 235-252
-
-
Krystal, J.H.1
D'Souza, D.C.2
Gallinat, J.3
-
100
-
-
34548084301
-
Enhanced nicotinic receptor function and drug abuse vulnerability
-
Fagen ZM, Mitchum R, Vezina P, McGehee DS. Enhanced nicotinic receptor function and drug abuse vulnerability. J Neurosci 2007;27:8771-8.
-
(2007)
J Neurosci
, vol.27
, pp. 8771-8778
-
-
Fagen, Z.M.1
Mitchum, R.2
Vezina, P.3
McGehee, D.S.4
-
102
-
-
0026495706
-
Comorbidity of schizophrenia and substance abuse: Implications for treatment
-
Mueser KT, Bellack AS, Blanchard JJ. Comorbidity of schizophrenia and substance abuse: implications for treatment. J Consult Clin Psychol 1992;60:845-56.
-
(1992)
J Consult Clin Psychol
, vol.60
, pp. 845-856
-
-
Mueser, K.T.1
Bellack, A.S.2
Blanchard, J.J.3
-
103
-
-
54749129410
-
The molecular and cellular neurobiology of nicotine abuse in schizophrenia
-
Mobascher A, Winterer G. The molecular and cellular neurobiology of nicotine abuse in schizophrenia. Pharmacopsychiatry 2008;41 suppl 1:S51-9.
-
(2008)
Pharmacopsychiatry
, vol.41
, Issue.SUPPL. 1
-
-
Mobascher, A.1
Winterer, G.2
-
104
-
-
0029085870
-
Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia
-
Freedman R, Hall M, Adler LE, Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 1995;38:22-33.
-
(1995)
Biol Psychiatry
, vol.38
, pp. 22-33
-
-
Freedman, R.1
Hall, M.2
Adler, L.E.3
Leonard, S.4
-
105
-
-
32844461888
-
Nicotinic effects on cognitive function: Behavioral characterization, pharmacological specification, and anatomic localization
-
Levin ED, McClernon FJ, Rezvani AH. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 2006;184:523-39.
-
(2006)
Psychopharmacology (Berl)
, vol.184
, pp. 523-539
-
-
Levin, E.D.1
McClernon, F.J.2
Rezvani, A.H.3
-
106
-
-
0027380988
-
Normalization of auditory physiology by cigarette smoking in schizophrenic patients
-
Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 1993;150:1856-61.
-
(1993)
Am J Psychiatry
, vol.150
, pp. 1856-1861
-
-
Adler, L.E.1
Hoffer, L.D.2
Wiser, A.3
Freedman, R.4
-
107
-
-
2942683373
-
Effects of nicotine on cognitive deficits in schizophrenia
-
Harris JG, Kongs S, Allensworth D, et al. Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 2004;29:1378-85.
-
(2004)
Neuropsychopharmacology
, vol.29
, pp. 1378-1385
-
-
Harris, J.G.1
Kongs, S.2
Allensworth, D.3
-
109
-
-
0028901714
-
Schizophrenia and smoking: An epidemiological survey in a state hospital
-
de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry 1995;152: 453-5.
-
(1995)
Am J Psychiatry
, vol.152
, pp. 453-455
-
-
De Leon, J.1
Dadvand, M.2
Canuso, C.3
White, A.O.4
Stanilla, J.K.5
Simpson, G.M.6
-
111
-
-
0036721408
-
Brain reward system activity in major depression and comorbid nicotine dependence
-
Cardenas L, Tremblay LK, Naranjo CA, Herrmann N, Zack M, Busto UE. Brain reward system activity in major depression and comorbid nicotine dependence. J Pharmacol Exp Ther 2002;302:1265-71.
-
(2002)
J Pharmacol Exp Ther
, vol.302
, pp. 1265-1271
-
-
Cardenas, L.1
Tremblay, L.K.2
Naranjo, C.A.3
Herrmann, N.4
Zack, M.5
Busto, U.E.6
-
112
-
-
2342479873
-
Substance-abusing schizophrenics: Do they self-medicate?
-
Goswami S, Mattoo SK, Basu D, Singh G. Substance-abusing schizophrenics: do they self-medicate? Am J Addict 2004;13: 139-50.
-
(2004)
Am J Addict
, vol.13
, pp. 139-150
-
-
Goswami, S.1
Mattoo, S.K.2
Basu, D.3
Singh, G.4
-
113
-
-
0347003609
-
Anhedonia, self-experience in schizophrenia, and implications for treatment
-
Juckel G, Sass L, Heinz A. Anhedonia, self-experience in schizophrenia, and implications for treatment. Pharmacopsychiatry 2003;36 suppl 3:S176-80.
-
(2003)
Pharmacopsychiatry
, vol.36
, Issue.SUPPL. 3
-
-
Juckel, G.1
Sass, L.2
Heinz, A.3
-
114
-
-
0033055995
-
Drug interactions with tobacco smoking. An update
-
Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 1999;36:425-38.
-
(1999)
Clin Pharmacokinet
, vol.36
, pp. 425-438
-
-
Zevin, S.1
Benowitz, N.L.2
-
115
-
-
0026005647
-
Effect of caffeine intake on psychotic in-patients
-
Zaslove MO, Russell RL, Ross E. Effect of caffeine intake on psychotic in-patients. Br J Psychiatry 1991;159:565-7.
-
(1991)
Br J Psychiatry
, vol.159
, pp. 565-567
-
-
Zaslove, M.O.1
Russell, R.L.2
Ross, E.3
-
117
-
-
2442495384
-
Atypical antipsychotic dosing: The effect of smoking and caffeine
-
de Leon J. Atypical antipsychotic dosing: the effect of smoking and caffeine. Psychiatr Serv 2004;55:491-3.
-
(2004)
Psychiatr Serv
, vol.55
, pp. 491-493
-
-
De Leon, J.1
-
118
-
-
20044381513
-
Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine
-
Haskell CF, Kennedy DO, Wesnes KA, Scholey AB. Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacology (Berl) 2005;179:813-25.
-
(2005)
Psychopharmacology (Berl)
, vol.179
, pp. 813-825
-
-
Haskell, C.F.1
Kennedy, D.O.2
Wesnes, K.A.3
Scholey, A.B.4
-
119
-
-
0034126287
-
Alteration of the behavioral effects of nicotine by chronic caffeine exposure
-
Tanda G, Goldberg SR. Alteration of the behavioral effects of nicotine by chronic caffeine exposure. Pharmacol Biochem Behav 2000;66:47-64.
-
(2000)
Pharmacol Biochem Behav
, vol.66
, pp. 47-64
-
-
Tanda, G.1
Goldberg, S.R.2
-
120
-
-
58249093825
-
Effectsofsmoking cues on caffeine urges in heavy smokers and caffeine consumers with and without schizophrenia
-
Adolfo AB, AhnAllen CG, Tidey JW. Effectsofsmoking cues on caffeine urges in heavy smokers and caffeine consumers with and without schizophrenia. Schizophr Res 2009;107:192-7.
-
(2009)
Schizophr Res
, vol.107
, pp. 192-197
-
-
Adolfo, A.B.1
AhnAllen, C.G.2
Tidey, J.W.3
-
121
-
-
33747180826
-
Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline
-
Nasrallah HA, Meyer JM, Goff DC, et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res 2006;86:15-22.
-
(2006)
Schizophr Res
, vol.86
, pp. 15-22
-
-
Nasrallah, H.A.1
Meyer, J.M.2
Goff, D.C.3
-
122
-
-
62549099817
-
Epidemiological study for the evaluation of metabolic disorders in patients with schizophrenia: The METEOR Study
-
De Hert M, Falissard B, Mauri M, Shaw K, Wetterling T. Epidemiological study for the evaluation of metabolic disorders in patients with schizophrenia: the METEOR Study. Eur Neuropsychopharmacol 2008;18(suppl 4):S444.
-
(2008)
Eur Neuropsychopharmacol
, vol.18
, Issue.SUPPL. 4
-
-
De Hert, M.1
Falissard, B.2
Mauri, M.3
Shaw, K.4
Wetterling, T.5
-
123
-
-
67650466009
-
Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder
-
Laursen TM, Munk-Olsen T, Agerbo E, Gasse C, Mortensen PB. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry 2009;66:713-20.
-
(2009)
Arch Gen Psychiatry
, vol.66
, pp. 713-720
-
-
Laursen, T.M.1
Munk-Olsen, T.2
Agerbo, E.3
Gasse, C.4
Mortensen, P.B.5
-
125
-
-
21244453135
-
Current therapy issues and unmet clinical needs in the treatment of schizophrenia: A review of the new generation antipsychotics
-
Lublin H, Eberhard J, Levander S. Current therapy issues and unmet clinical needs in the treatment of schizophrenia: a review of the new generation antipsychotics. Int Clin Psychopharmacol 2005;20:183-98.
-
(2005)
Int Clin Psychopharmacol
, vol.20
, pp. 183-198
-
-
Lublin, H.1
Eberhard, J.2
Levander, S.3
-
126
-
-
35048827065
-
Adverse effects of atypical anti-psychotics: Differential risk and clinical implications
-
Haddad PM, Sharma SG. Adverse effects of atypical anti-psychotics: differential risk and clinical implications. CNS Drugs 2007;21:911-36.
-
(2007)
CNS Drugs
, vol.21
, pp. 911-936
-
-
Haddad, P.M.1
Sharma, S.G.2
-
127
-
-
0038014053
-
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs
-
Kroeze WK, Hufeisen SJ, Popadak BA, et al. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 2003;28:519-26.
-
(2003)
Neuropsychopharmacology
, vol.28
, pp. 519-526
-
-
Kroeze, W.K.1
Hufeisen, S.J.2
Popadak, B.A.3
-
129
-
-
15744364142
-
Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine
-
Ellingrod VL, Perry PJ, Ringold JC, et al. Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine. Am J Med Genet B Neuropsychiatr Genet 2005;134B:76-8.
-
(2005)
Am J Med Genet B Neuropsychiatr Genet
, vol.134 B
, pp. 76-78
-
-
Ellingrod, V.L.1
Perry, P.J.2
Ringold, J.C.3
-
131
-
-
47949104798
-
The role of exercise and PGC1alpha in inflammation and chronic disease
-
Handschin C, Spiegelman BM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008; 454:463-9.
-
(2008)
Nature
, vol.454
, pp. 463-469
-
-
Handschin, C.1
Spiegelman, B.M.2
-
132
-
-
0032749573
-
Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men
-
Wei M, Kampert JB, Barlow CE, et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA 1999;282: 1547-53.
-
(1999)
JAMA
, vol.282
, pp. 1547-1553
-
-
Wei, M.1
Kampert, J.B.2
Barlow, C.E.3
-
133
-
-
10844262691
-
Adiposity as compared with physical activity in predicting mortality among women
-
Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, Manson JE. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 2004;351: 2694-703.
-
(2004)
N Engl J Med
, vol.351
, pp. 2694-2703
-
-
Hu, F.B.1
Willett, W.C.2
Li, T.3
Stampfer, M.J.4
Colditz, G.A.5
Manson, J.E.6
-
134
-
-
42249090877
-
A life course of adiposity and dementia
-
Gustafson D. A life course of adiposity and dementia. Eur J Pharmacol 2008;585:163-75.
-
(2008)
Eur J Pharmacol
, vol.585
, pp. 163-175
-
-
Gustafson, D.1
-
135
-
-
84870540270
-
Energy intake and exercise as determinants of brain health and vulnerability to injury and disease
-
Mattson MP. Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metab 2012;16:706-22.
-
(2012)
Cell Metab
, vol.16
, pp. 706-722
-
-
Mattson, M.P.1
-
136
-
-
18744366088
-
Second-generation (atypical) antipsychotics and metabolic effects: A comprehensive literature review
-
Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005;19 suppl 1:1-93.
-
(2005)
CNS Drugs
, vol.19
, Issue.SUPPL. 1
, pp. 1-93
-
-
Newcomer, J.W.1
-
137
-
-
2442509785
-
Hyperlipidemia in persons using antipsychotic medication: A general population-based birth cohort study
-
Saari K, Koponen H, Laitinen J, et al. Hyperlipidemia in persons using antipsychotic medication: a general population-based birth cohort study. J Clin Psychiatry 2004;65:547-50.
-
(2004)
J Clin Psychiatry
, vol.65
, pp. 547-550
-
-
Saari, K.1
Koponen, H.2
Laitinen, J.3
-
138
-
-
1842739590
-
Adverse metabolic effects associated with atypical antipsychotics: Literature review and clinical implications
-
Melkersson K, Dahl ML. Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications. Drugs 2004;64:701-23.
-
(2004)
Drugs
, vol.64
, pp. 701-723
-
-
Melkersson, K.1
Dahl, M.L.2
-
140
-
-
0034954068
-
Major system toxicities and side effects of anticonvulsants
-
Swann AC. Major system toxicities and side effects of anticonvulsants. J Clin Psychiatry 2001;62 suppl 14:16-21.
-
(2001)
J Clin Psychiatry
, vol.62
, Issue.SUPPL. 14
, pp. 16-21
-
-
Swann, A.C.1
-
141
-
-
79953054796
-
Diabetes and depression? Secular trends in the use of antidepressants among persons with diabetes in Finland in 1997-2007
-
Manderbacka K, Sund R, Koski S, Keskimaki I, Elovainio M. Diabetes and depression? Secular trends in the use of antidepressants among persons with diabetes in Finland in 1997-2007. Pharmacoepidemiol Drug Saf 2011;20:338-43.
-
(2011)
Pharmacoepidemiol Drug Saf
, vol.20
, pp. 338-343
-
-
Manderbacka, K.1
Sund, R.2
Koski, S.3
Keskimaki, I.4
Elovainio, M.5
-
142
-
-
77950891328
-
Subjective tolerability of antipsychotic medications and the emerging science of subjective tolerability disorders
-
Awad AG. Subjective tolerability of antipsychotic medications and the emerging science of subjective tolerability disorders. Expert Rev Pharmacoecon Outcomes Res 2010;10:1-4.
-
(2010)
Expert Rev Pharmacoecon Outcomes Res
, vol.10
, pp. 1-4
-
-
Awad, A.G.1
-
143
-
-
2642515398
-
Is neuroleptic dysphoria a variant of drug-induced extrapyramidal side effects?
-
Voruganti LP, Awad AG. Is neuroleptic dysphoria a variant of drug-induced extrapyramidal side effects? Can J Psychiatry 2004;49:285-9.
-
(2004)
Can J Psychiatry
, vol.49
, pp. 285-289
-
-
Voruganti, L.P.1
Awad, A.G.2
-
144
-
-
0036886986
-
Safety and tolerability: How do newer generation "atypical" antipsychotics compare?
-
Tandon R. Safety and tolerability: how do newer generation "atypical" antipsychotics compare? Psychiatr Q 2002;73: 297-311.
-
(2002)
Psychiatr Q
, vol.73
, pp. 297-311
-
-
Tandon, R.1
-
145
-
-
34247533866
-
Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: A PET study in schizophrenia
-
Mizrahi R, Rusjan P, Agid O, et al. Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia. Am J Psychiatry 2007;164:630-7.
-
(2007)
Am J Psychiatry
, vol.164
, pp. 630-637
-
-
Mizrahi, R.1
Rusjan, P.2
Agid, O.3
-
146
-
-
84889958809
-
Role of dopamine in pleasure, reward and subjective responses to drugs. The neuropsycho-pharmacology of quality of life in schizophrenia
-
Ritsner MS, Awad AG, eds. Dordrecht: Springer
-
Voruganti LNP, Awad AG. Role of dopamine in pleasure, reward and subjective responses to drugs. The neuropsycho-pharmacology of quality of life in schizophrenia. In: Ritsner MS, Awad AG, eds. Quality of life impairment in schizophrenia, mood and anxiety disorders. Dordrecht: Springer, 2007.
-
(2007)
Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders
-
-
Voruganti, L.N.P.1
Awad, A.G.2
-
147
-
-
0037313398
-
Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: A randomized, double-blind study
-
de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. Am J Psychiatry 2003;160:303-9.
-
(2003)
Am J Psychiatry
, vol.160
, pp. 303-309
-
-
De Haan, L.1
Van Bruggen, M.2
Lavalaye, J.3
Booij, J.4
Dingemans, P.M.5
Linszen, D.6
-
148
-
-
0029946719
-
High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: A PET study
-
Kapur S, Remington G, Jones C, et al. High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. Am J Psychiatry 1996;153:948-50.
-
(1996)
Am J Psychiatry
, vol.153
, pp. 948-950
-
-
Kapur, S.1
Remington, G.2
Jones, C.3
-
149
-
-
0027520871
-
Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients
-
Nordstrom AL, Farde L, Wiesel FA, et al. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol Psychiatry 1993;33:227-35.
-
(1993)
Biol Psychiatry
, vol.33
, pp. 227-235
-
-
Nordstrom, A.L.1
Farde, L.2
Wiesel, F.A.3
-
150
-
-
0034109940
-
Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action
-
Kapur S, Seeman P. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. J Psychiatry Neurosci 2000;25:161-6.
-
(2000)
J Psychiatry Neurosci
, vol.25
, pp. 161-166
-
-
Kapur, S.1
Seeman, P.2
-
151
-
-
0030785601
-
Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse
-
Voruganti LN, Heslegrave RJ, Awad AG. Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse. J Nerv Ment Dis 1997;185:463-5.
-
(1997)
J Nerv Ment Dis
, vol.185
, pp. 463-465
-
-
Voruganti, L.N.1
Heslegrave, R.J.2
Awad, A.G.3
-
152
-
-
0642366895
-
Pharmacotherapy for schizophrenia and co-occurring substance use disorders
-
Noordsy DL, Green AI. Pharmacotherapy for schizophrenia and co-occurring substance use disorders. Curr Psychiatry Rep 2003;5:340-6.
-
(2003)
Curr Psychiatry Rep
, vol.5
, pp. 340-346
-
-
Noordsy, D.L.1
Green, A.I.2
-
153
-
-
0028119158
-
Clozapine attenuates cocaine conditioned place preference
-
Kosten TA, Nestler EJ. Clozapine attenuates cocaine conditioned place preference. Life Sci 1994;55:PL9-14.
-
(1994)
Life Sci
, vol.55
-
-
Kosten, T.A.1
Nestler, E.J.2
-
154
-
-
0035479031
-
Cannabis induced dopamine release: An in-vivo SPECT study
-
Voruganti LN, Slomka P, Zabel P, Mattar A, Awad AG. Cannabis induced dopamine release: an in-vivo SPECT study. Psychiatry Res 2001;107:173-7.
-
(2001)
Psychiatry Res
, vol.107
, pp. 173-177
-
-
Voruganti, L.N.1
Slomka, P.2
Zabel, P.3
Mattar, A.4
Awad, A.G.5
-
155
-
-
12644293806
-
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
-
Breier A, Su TP, Saunders R, et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A 1997;94:2569-74.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 2569-2574
-
-
Breier, A.1
Su, T.P.2
Saunders, R.3
-
156
-
-
0029010819
-
SPECT imaging of striatal dopamine release after amphetamine challenge
-
Laruelle M, Abi-Dargham A, van Dyck CH, et al. SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med 1995;36:1182-90.
-
(1995)
J Nucl Med
, vol.36
, pp. 1182-1190
-
-
Laruelle, M.1
Abi-Dargham, A.2
Van Dyck, C.H.3
-
157
-
-
0030799746
-
PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects
-
Schlaepfer TE, Pearlson GD, Wong DF, Marenco S, Dannals RF. PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects. Am J Psychiatry 1997;154:1209-13.
-
(1997)
Am J Psychiatry
, vol.154
, pp. 1209-1213
-
-
Schlaepfer, T.E.1
Pearlson, G.D.2
Wong, D.F.3
Marenco, S.4
Dannals, R.F.5
-
158
-
-
15744398700
-
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
-
D'Souza DC, Abi-Saab WM, Madonick S, et al. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry 2005; 57:594-608.
-
(2005)
Biol Psychiatry
, vol.57
, pp. 594-608
-
-
D'Souza, D.C.1
Abi-Saab, W.M.2
Madonick, S.3
-
159
-
-
33745119452
-
Striatal dopamine release and family history of alcoholism
-
Munro CA, McCaul ME, Oswald LM, et al. Striatal dopamine release and family history of alcoholism. Alcohol Clin Exp Res 2006;30:1143-51.
-
(2006)
Alcohol Clin Exp Res
, vol.30
, pp. 1143-1151
-
-
Munro, C.A.1
McCaul, M.E.2
Oswald, L.M.3
-
160
-
-
15444373514
-
Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine
-
Oswald LM, Wong DF, McCaul M, et al. Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Neuropsychopharmacology 2005;30:821-32.
-
(2005)
Neuropsychopharmacology
, vol.30
, pp. 821-832
-
-
Oswald, L.M.1
Wong, D.F.2
McCaul, M.3
-
161
-
-
0030751189
-
Effects of haloperidol and amisulpride on motor and cognitive skill learning in healthy volunteers
-
Peretti CS, Danion JM, Kauffmann-Muller F, Grange D, Patat A, Rosenzweig P. Effects of haloperidol and amisulpride on motor and cognitive skill learning in healthy volunteers. Psychopharmacology (Berl) 1997;131:329-38.
-
(1997)
Psychopharmacology (Berl)
, vol.131
, pp. 329-338
-
-
Peretti, C.S.1
Danion, J.M.2
Kauffmann-Muller, F.3
Grange, D.4
Patat, A.5
Rosenzweig, P.6
-
162
-
-
33745404437
-
Impact of haloperidol, a dopamine D2 antagonist, on cognition and mood
-
Saeedi H, Remington G, Christensen BK. Impact of haloperidol, a dopamine D2 antagonist, on cognition and mood. Schizophr Res 2006;85:222-31.
-
(2006)
Schizophr Res
, vol.85
, pp. 222-231
-
-
Saeedi, H.1
Remington, G.2
Christensen, B.K.3
-
163
-
-
77749252588
-
The effect of dopamine partial agonists on the nicotine dependency in patients with schizophrenia
-
Kim SH, Han DH, Joo SY, Min KJ. The effect of dopamine partial agonists on the nicotine dependency in patients with schizophrenia. Hum Psychopharmacol 2010;25:187-90.
-
(2010)
Hum Psychopharmacol
, vol.25
, pp. 187-190
-
-
Kim, S.H.1
Han, D.H.2
Joo, S.Y.3
Min, K.J.4
-
164
-
-
28344456936
-
Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia
-
de Haan L, Booij J, Lavalaye J, van Amelsvoort T, Linszen D. Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia. Psychopharmacology (Berl) 2006;183:500-5.
-
(2006)
Psychopharmacology (Berl)
, vol.183
, pp. 500-505
-
-
De Haan, L.1
Booij, J.2
Lavalaye, J.3
Van Amelsvoort, T.4
Linszen, D.5
-
165
-
-
0028918837
-
Clozapine decreases smoking in patients with chronic schizophrenia
-
McEvoy J, Freudenreich O, McGee M, VanderZwaag C, Levin E, Rose J. Clozapine decreases smoking in patients with chronic schizophrenia. Biol Psychiatry 1995;37:550-2.
-
(1995)
Biol Psychiatry
, vol.37
, pp. 550-552
-
-
McEvoy, J.1
Freudenreich, O.2
McGee, M.3
VanderZwaag, C.4
Levin, E.5
Rose, J.6
-
166
-
-
2442565645
-
Chronic nicotine and smoking treatment increases dopamine transporter mRNA expression in the rat midbrain
-
Li S, Kim KY, Kim JH, Park MS, Bahk JY, Kim MO. Chronic nicotine and smoking treatment increases dopamine transporter mRNA expression in the rat midbrain. Neurosci Lett 2004;363:29-32.
-
(2004)
Neurosci Lett
, vol.363
, pp. 29-32
-
-
Li, S.1
Kim, K.Y.2
Kim, J.H.3
Park, M.S.4
Bahk, J.Y.5
Kim, M.O.6
-
167
-
-
0242667143
-
Nicotinic receptor-mediated regulation of the dopamine transporter in rat prefrontocortical slices following chronic in vivo administration of nicotine
-
Drew AE, Werling LL. Nicotinic receptor-mediated regulation of the dopamine transporter in rat prefrontocortical slices following chronic in vivo administration of nicotine. Schizophr Res 2003;65:47-55.
-
(2003)
Schizophr Res
, vol.65
, pp. 47-55
-
-
Drew, A.E.1
Werling, L.L.2
-
168
-
-
0036789821
-
Nicotine decreases bradykinesia-rigidity in haloperidoltreated patients with schizophrenia
-
Yang YK, Nelson L, Kamaraju L, Wilson W, McEvoy JP. Nicotine decreases bradykinesia-rigidity in haloperidoltreated patients with schizophrenia. Neuropsychopharmacology 2002;27:684-6.
-
(2002)
Neuropsychopharmacology
, vol.27
, pp. 684-686
-
-
Yang, Y.K.1
Nelson, L.2
Kamaraju, L.3
Wilson, W.4
McEvoy, J.P.5
-
169
-
-
0030827472
-
Treatment of neuroleptic-induced akathisia with nicotine patches
-
Anfang MK, Pope HG Jr. Treatment of neuroleptic-induced akathisia with nicotine patches. Psychopharmacology (Berl) 1997;134:153-6.
-
(1997)
Psychopharmacology (Berl)
, vol.134
, pp. 153-156
-
-
Anfang, M.K.1
Pope Jr., H.G.2
-
170
-
-
0026800996
-
Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects
-
Goff DC, Henderson DC, Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am J Psychiatry 1992;149:1189-94.
-
(1992)
Am J Psychiatry
, vol.149
, pp. 1189-1194
-
-
Goff, D.C.1
Henderson, D.C.2
Amico, E.3
-
171
-
-
1642523514
-
Does nicotine affect D2 receptor upregulation? A case-control study
-
discussion 7-8
-
Silvestri S, Negrete JC, Seeman MV, Shammi CM, Seeman P. Does nicotine affect D2 receptor upregulation? A case-control study. Acta Psychiatr Scand 2004;109:313-7; discussion 7-8.
-
(2004)
Acta Psychiatr Scand
, vol.109
, pp. 313-317
-
-
Silvestri, S.1
Negrete, J.C.2
Seeman, M.V.3
Shammi, C.M.4
Seeman, P.5
-
172
-
-
0023748070
-
Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes
-
Seeman P. Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes. J Clin Psychopharmacol 1988;8:3S-9S.
-
(1988)
J Clin Psychopharmacol
, vol.8
-
-
Seeman, P.1
-
173
-
-
1442264400
-
Association of anticholinergic load with impairment of complex attention and memory in schizophrenia
-
Minzenberg MJ, Poole JH, Benton C, Vinogradov S. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. Am J Psychiatry 2004;161:116-24.
-
(2004)
Am J Psychiatry
, vol.161
, pp. 116-124
-
-
Minzenberg, M.J.1
Poole, J.H.2
Benton, C.3
Vinogradov, S.4
-
174
-
-
69949103030
-
The cognitive cost of anticholinergic burden: Decreased response to cognitive training in schizophrenia
-
Vinogradov S, Fisher M, Warm H, Holland C, Kirshner MA, Pollock BG. The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. Am J Psychiatry 2009;166:1055-62.
-
(2009)
Am J Psychiatry
, vol.166
, pp. 1055-1062
-
-
Vinogradov, S.1
Fisher, M.2
Warm, H.3
Holland, C.4
Kirshner, M.A.5
Pollock, B.G.6
-
175
-
-
0030297344
-
Nicotine-haloperidol interactions and cognitive performance in schizophrenics
-
Levin ED, Wilson W, Rose JE, McEvoy J. Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 1996;15:429-36.
-
(1996)
Neuropsychopharmacology
, vol.15
, pp. 429-436
-
-
Levin, E.D.1
Wilson, W.2
Rose, J.E.3
McEvoy, J.4
-
176
-
-
11844263996
-
Tobacco use in schizophrenia: A study of cotinine concentrations in the saliva of patients and controls
-
Strand JE, Nyback H. Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls. Eur Psychiatry 2005;20:50-4.
-
(2005)
Eur Psychiatry
, vol.20
, pp. 50-54
-
-
Strand, J.E.1
Nyback, H.2
-
177
-
-
33747159598
-
Does smoking reduce akathisia? Testing a narrow version of the self-medication hypothesis
-
de Leon J, Diaz FJ, Aguilar MC, Jurado D, Gurpegui M. Does smoking reduce akathisia? Testing a narrow version of the self-medication hypothesis. Schizophr Res 2006;86: 256-68.
-
(2006)
Schizophr Res
, vol.86
, pp. 256-268
-
-
De Leon, J.1
Diaz, F.J.2
Aguilar, M.C.3
Jurado, D.4
Gurpegui, M.5
-
178
-
-
78349232049
-
Reasons for substance use among adolescents with bipolar disorder
-
Lorberg B, Wilens TE, Martelon M, Wong P, Parcell T. Reasons for substance use among adolescents with bipolar disorder. Am J Addict 2010;19:474-80.
-
(2010)
Am J Addict
, vol.19
, pp. 474-480
-
-
Lorberg, B.1
Wilens, T.E.2
Martelon, M.3
Wong, P.4
Parcell, T.5
-
179
-
-
0030758520
-
Augmentation of opioid induced antinociception by the atypical antipsychotic drug risperidone in mice
-
Schreiber S, Backer MM, Weizman R, Pick CG. Augmentation of opioid induced antinociception by the atypical antipsychotic drug risperidone in mice. Neurosci Lett 1997; 228:25-8.
-
(1997)
Neurosci Lett
, vol.228
, pp. 25-28
-
-
Schreiber, S.1
Backer, M.M.2
Weizman, R.3
Pick, C.G.4
-
180
-
-
0032885115
-
The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency
-
Schreiber S, Getslev V, Backer MM, Weizman R, Pick CG. The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency. Pharmacol Biochem Behav 1999;64:75-80.
-
(1999)
Pharmacol Biochem Behav
, vol.64
, pp. 75-80
-
-
Schreiber, S.1
Getslev, V.2
Backer, M.M.3
Weizman, R.4
Pick, C.G.5
-
181
-
-
0142138311
-
The antinociceptive effect of amisulpride in mice is mediated through opioid mechanisms
-
Weizman T, Pick CG, Backer MM, Rigai T, Bloch M, Schreiber S. The antinociceptive effect of amisulpride in mice is mediated through opioid mechanisms. Eur J Pharmacol 2003;478:155-9.
-
(2003)
Eur J Pharmacol
, vol.478
, pp. 155-159
-
-
Weizman, T.1
Pick, C.G.2
Backer, M.M.3
Rigai, T.4
Bloch, M.5
Schreiber, S.6
-
182
-
-
0036345129
-
Improvement in the level of psychosocial functioning in chronic pain patients with the use of risperidone
-
Fe-Bornstein M, Watt SD, Gitlin MC. Improvement in the level of psychosocial functioning in chronic pain patients with the use of risperidone. Pain Med 2002;3:128-31.
-
(2002)
Pain Med
, vol.3
, pp. 128-131
-
-
Fe-Bornstein, M.1
Watt, S.D.2
Gitlin, M.C.3
-
183
-
-
0034902625
-
Olanzapine for the treatment of fibromyalgia symptoms
-
Kiser RS, Cohen HM, Freedenfeld RN, Jewell C, Fuchs PN. Olanzapine for the treatment of fibromyalgia symptoms. J Pain Symptom Manage 2001;22:704-8.
-
(2001)
J Pain Symptom Manage
, vol.22
, pp. 704-708
-
-
Kiser, R.S.1
Cohen, H.M.2
Freedenfeld, R.N.3
Jewell, C.4
Fuchs, P.N.5
-
184
-
-
0036617585
-
Olanzapine in the treatment of refractory migraine and chronic daily headache
-
Silberstein SD, Peres MF, Hopkins MM, Shechter AL, Young WB, Rozen TD. Olanzapine in the treatment of refractory migraine and chronic daily headache. Headache 2002;42:515-8.
-
(2002)
Headache
, vol.42
, pp. 515-518
-
-
Silberstein, S.D.1
Peres, M.F.2
Hopkins, M.M.3
Shechter, A.L.4
Young, W.B.5
Rozen, T.D.6
-
185
-
-
0029585619
-
The therapeutic role of naltrexone in negative symptom schizophrenia
-
Marchesi GF, Santone G, Cotani P, Giordano A, Chelli F. The therapeutic role of naltrexone in negative symptom schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:1239-49.
-
(1995)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.19
, pp. 1239-1249
-
-
Marchesi, G.F.1
Santone, G.2
Cotani, P.3
Giordano, A.4
Chelli, F.5
-
186
-
-
0036062648
-
Opioid modulation of taste hedonics within the ventral striatum
-
Kelley AE, Bakshi VP, Haber SN, Steininger TL, Will MJ, Zhang M. Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav 2002;76:365-77.
-
(2002)
Physiol Behav
, vol.76
, pp. 365-377
-
-
Kelley, A.E.1
Bakshi, V.P.2
Haber, S.N.3
Steininger, T.L.4
Will, M.J.5
Zhang, M.6
-
187
-
-
0037390212
-
Nucleus accumbens muopioids regulate intake of a high-fat diet via activation of a distributed brain network
-
Will MJ, Franzblau EB, Kelley AE. Nucleus accumbens muopioids regulate intake of a high-fat diet via activation of a distributed brain network. J Neurosci 2003;23:2882-8.
-
(2003)
J Neurosci
, vol.23
, pp. 2882-2888
-
-
Will, M.J.1
Franzblau, E.B.2
Kelley, A.E.3
-
188
-
-
12144290655
-
Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia
-
Petrakis IL, O'Malley S, Rounsaville B, Poling J, McHugh-Strong C, Krystal JH. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia. Psychopharmacology (Berl) 2004;172:291-7.
-
(2004)
Psychopharmacology (Berl)
, vol.172
, pp. 291-297
-
-
Petrakis, I.L.1
O'Malley, S.2
Rounsaville, B.3
Poling, J.4
McHugh-Strong, C.5
Krystal, J.H.6
-
189
-
-
13044268459
-
Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder
-
Robinson D, Woerner MG, Alvir JM, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999;56:241-7.
-
(1999)
Arch Gen Psychiatry
, vol.56
, pp. 241-247
-
-
Robinson, D.1
Woerner, M.G.2
Alvir, J.M.3
-
190
-
-
30344459999
-
Risk and protection in prodromal schizophrenia: Ethical implications for clinical practice and future research
-
Haroun N, Dunn L, Haroun A, Cadenhead KS. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future
-
(2006)
Schizophr Bull
, vol.32
, pp. 166-178
-
-
Haroun, N.1
Dunn, L.2
Haroun, A.3
Cadenhead, K.S.4
-
191
-
-
85047695195
-
Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis
-
McGlashan TH, Zipursky RB, Perkins D, et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006;163:790-9.
-
(2006)
Am J Psychiatry
, vol.163
, pp. 790-799
-
-
McGlashan, T.H.1
Zipursky, R.B.2
Perkins, D.3
-
192
-
-
0037400949
-
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample
-
Miller TJ, Zipursky RB, Perkins D, et al. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample. Schizophr Res 2003;61:19-30.
-
(2003)
Schizophr Res
, vol.61
, pp. 19-30
-
-
Miller, T.J.1
Zipursky, R.B.2
Perkins, D.3
-
193
-
-
44949167544
-
Cognitive behavior therapy for schizophrenia: Effect sizes, clinical models, and methodological rigor
-
Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 2008;34:523-37.
-
(2008)
Schizophr Bull
, vol.34
, pp. 523-537
-
-
Wykes, T.1
Steel, C.2
Everitt, B.3
Tarrier, N.4
-
194
-
-
33646188853
-
A wellness class for inpatients with psychotic disorders
-
Wirshing DA, Smith RA, Erickson ZD, Mena SJ, Wirshing WC. A wellness class for inpatients with psychotic disorders. J Psychiatr Pract 2006;12:24-9.
-
(2006)
J Psychiatr Pract
, vol.12
, pp. 24-29
-
-
Wirshing, D.A.1
Smith, R.A.2
Erickson, Z.D.3
Mena, S.J.4
Wirshing, W.C.5
-
195
-
-
0043131961
-
A program for managing weight gain associated with atypical antipsychotics
-
Wreeland B, Minski S, Menza M, Radler DR, Roemheld-Hamm B, Stern R. A program for managing weight gain associated with atypical antipsychotics. Psychiatr Serv 2003; 54:1155-7.
-
(2003)
Psychiatr Serv
, vol.54
, pp. 1155-1157
-
-
Wreeland, B.1
Minski, S.2
Menza, M.3
Radler, D.R.4
Roemheld-Hamm, B.5
Stern, R.6
-
196
-
-
33847246338
-
Serious mental illness and physical health problems: A discussion paper
-
Robson D, Gray R. Serious mental illness and physical health problems: a discussion paper. Int J Nurs Stud 2007; 44:457-66.
-
(2007)
Int J Nurs Stud
, vol.44
, pp. 457-466
-
-
Robson, D.1
Gray, R.2
-
197
-
-
79956283069
-
Food restriction enhances visual cortex plasticity in adulthood
-
Spolidoro M, Baroncelli L, Putignano E, Maya-Vetencourt JF, Viegi A, Maffei L. Food restriction enhances visual cortex plasticity in adulthood. Nat Commun 2011;2:320.
-
(2011)
Nat Commun
, vol.2
, pp. 320
-
-
Spolidoro, M.1
Baroncelli, L.2
Putignano, E.3
Maya-Vetencourt, J.F.4
Viegi, A.5
Maffei, L.6
-
199
-
-
80054691291
-
Exercise training increases mitochondrial biogenesis in the brain
-
Steiner JL, Murphy EA, McClellan JL, Carmichael MD, Davis JM. Exercise training increases mitochondrial biogenesis in the brain. J Appl Physiol 2011;111:1066-71.
-
(2011)
J Appl Physiol
, vol.111
, pp. 1066-1071
-
-
Steiner, J.L.1
Murphy, E.A.2
McClellan, J.L.3
Carmichael, M.D.4
Davis, J.M.5
-
200
-
-
33847417457
-
Psychotic disorders, eating habits, and physical activity: Who is ready for lifestyle changes?
-
Archie SM, Goldberg JO, Akhtar-Danesh N, Landeen J, McColl L, McNiven J. Psychotic disorders, eating habits, and physical activity: who is ready for lifestyle changes? Psychiatr Serv 2007;58:233-9.
-
(2007)
Psychiatr Serv
, vol.58
, pp. 233-239
-
-
Archie, S.M.1
Goldberg, J.O.2
Akhtar-Danesh, N.3
Landeen, J.4
McColl, L.5
McNiven, J.6
-
201
-
-
0042338703
-
Vocational rehabilitation in schizophrenia and other psychotic disorders: A literature review and meta-analysis of randomized controlled trials
-
Twamley EW, Jeste DV, Lehman AF. Vocational rehabilitation in schizophrenia and other psychotic disorders: a literature review and meta-analysis of randomized controlled trials. J Nerv Ment Dis 2003;191:515-23.
-
(2003)
J Nerv Ment Dis
, vol.191
, pp. 515-523
-
-
Twamley, E.W.1
Jeste, D.V.2
Lehman, A.F.3
-
202
-
-
0041328134
-
Clinical interventions for treatment non-adherence in psychosis: Meta-analysis
-
Nose M, Barbui C, Gray R, Tansella M. Clinical interventions for treatment non-adherence in psychosis: meta-analysis. Br J Psychiatry 2003;183:197-206.
-
(2003)
Br J Psychiatry
, vol.183
, pp. 197-206
-
-
Nose, M.1
Barbui, C.2
Gray, R.3
Tansella, M.4
-
203
-
-
34548175719
-
Use of intensive case management to reduce time in hospital in people with severe mental illness: Systematic review and meta-regression
-
Burns T, Catty J, Dash M, Roberts C, Lockwood A, Marshall M. Use of intensive case management to reduce time in hospital in people with severe mental illness: systematic review and meta-regression. BMJ 2007;335:336.
-
(2007)
BMJ
, vol.335
, pp. 336
-
-
Burns, T.1
Catty, J.2
Dash, M.3
Roberts, C.4
Lockwood, A.5
Marshall, M.6
-
204
-
-
67649177544
-
Topiramate add-on treatment in schizophrenia: A randomised, double-blind, placebocontrolled clinical trial
-
Afshar H, Roohafza H, Mousavi G, et al. Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebocontrolled clinical trial. J Psychopharmacol 2009;23:157-62.
-
(2009)
J Psychopharmacol
, vol.23
, pp. 157-162
-
-
Afshar, H.1
Roohafza, H.2
Mousavi, G.3
-
205
-
-
34447506399
-
Topiramate-induced weight loss in schizophrenia: A retrospective case series study
-
Levy E, Agbokou C, Ferreri F, Chouinard G, Margolese HC. Topiramate-induced weight loss in schizophrenia: a retrospective case series study. Can J Clin Pharmacol 2007;14:e234-9.
-
(2007)
Can J Clin Pharmacol
, vol.14
-
-
Levy, E.1
Agbokou, C.2
Ferreri, F.3
Chouinard, G.4
Margolese, H.C.5
-
206
-
-
0642282677
-
Effects of environmental enrichment at ages 3-5 years on schizotypal personality and antisocial behavior at ages 17 and 23 years
-
Raine A, Mellingen K, Liu J, Venables P, Mednick SA. Effects of environmental enrichment at ages 3-5 years on schizotypal personality and antisocial behavior at ages 17 and 23 years. Am J Psychiatry 2003;160:1627-35.
-
(2003)
Am J Psychiatry
, vol.160
, pp. 1627-1635
-
-
Raine, A.1
Mellingen, K.2
Liu, J.3
Venables, P.4
Mednick, S.A.5
-
207
-
-
0032937814
-
Biology and the future of psychoanalysis: A new intellectual framework for psychiatry revisited
-
Kandel ER. Biology and the future of psychoanalysis: a new intellectual framework for psychiatry revisited. Am J Psychiatry 1999;156:505-24.
-
(1999)
Am J Psychiatry
, vol.156
, pp. 505-524
-
-
Kandel, E.R.1
-
208
-
-
68949188168
-
Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?
-
Vinogradov S, Fisher M, Holland C, Shelly W, Wolkowitz O, Mellon SH. Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia? Biol Psychiatry 2009;66:549-53.
-
(2009)
Biol Psychiatry
, vol.66
, pp. 549-553
-
-
Vinogradov, S.1
Fisher, M.2
Holland, C.3
Shelly, W.4
Wolkowitz, O.5
Mellon, S.H.6
-
209
-
-
48949116396
-
Integrating biological measures into the design and evaluation of preventive interventions
-
Cicchetti D, Gunnar MR. Integrating biological measures into the design and evaluation of preventive interventions. Dev Psychopathol 2008;20:737-43.
-
(2008)
Dev Psychopathol
, vol.20
, pp. 737-743
-
-
Cicchetti, D.1
Gunnar, M.R.2
-
210
-
-
40849133755
-
Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators
-
McEwen BS. Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 2008;583:174-85.
-
(2008)
Eur J Pharmacol
, vol.583
, pp. 174-185
-
-
McEwen, B.S.1
|